Trofinetide Uses, Dosage, Side Effects and Interactions
Daybue
Daybue was approved by the FDA in March 2023 as an oral solution. No generic is listed as oral solution.
Daybue Stix
Daybue Stix was approved by the FDA in December 2025 as an oral solution. No generic is listed as oral solution.
Trofinetide is a prescription medicine used to treat Rett syndrome in adults and children 2 years of age and older.
Quick links
Ask Anything About TrofinetideType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Trofinetide in Short
What it treatsTrofinetide treats Rett syndrome in adults and pediatric patients 2 years of age and older. It is sold as Daybue (oral solution) and Daybue Stix (powder that is dissolved in liquid to make an oral solution). Both carry this same use.
- How you get it Prescription only
- Comes asOral solution (by mouth)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs30 interact 1 major, 19 moderate and 10 minor
- What Medicaid pays
- Daybue (brand)$23.73 per mL
- Generic launch2038 to 2039 Daybue Stix: 2038 to 2039 Our estimate for the first generic of Daybue
The Pharmacist’s Take
Trofinetide (Daybue) is the first medicine approved specifically for Rett syndrome in adults and children 2 and older. It is a specialist drug, on the market only since about 2022, with no generic yet, and how it works is still unknown. Diarrhea is the side effect most people notice, usually mild to moderate but often lasting, and vomiting, poor appetite and weight loss can follow. Watch hydration and weight closely, and call the care team early if diarrhea turns severe or dehydration seems likely. Rett syndrome already raises the risk of aspiration (stomach contents getting into the lungs), so coughing or trouble breathing after vomiting needs urgent care.
Key Takeaways From the HelloPharmacist Team
- Give it twice a day, morning and evening, by mouth or through a G-tube, with or without food.
- Stop any laxatives before the first dose, and plan for extra fluids from day one since diarrhea is expected.
- If a dose is missed or vomited up, skip it and give the next one at the usual time, never doubling up.
- Check with your pharmacist before using loperamide or starting other medicines, since trofinetide can raise blood levels of loperamide and many other drugs.
Patient Information Guide for Trofinetide
What It’s Used For
Trofinetide is used for one condition.
- Rett syndrome in adults and pediatric patients 2 years of age and older (Daybue and Daybue Stix).
How It Works
The way trofinetide helps people with Rett syndrome is not known. Researchers have not pinned down its exact mechanism.
Drug Class
How It Works
- Cytochrome P450 3A4 Inhibitors
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 1B3 Inhibitors
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None listed for Trofinetide in the FDA’s index.
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Cytochrome P450 3A4 Inhibitors
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 1B3 Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Trofinetide in the FDA’s index.
From our Patient Information GuideThe way trofinetide helps people with Rett syndrome is not known. Researchers have not pinned down its exact mechanism. Read How Trofinetide Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Trofinetide in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other nervous system drugs
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Trofinetide is taken by mouth or through a G tube twice daily, morning and evening, with or without food. The amount is based on body weight and kidney function.
- Daybue oral solution: measure with an oral syringe or dosing cup from the pharmacy.
- Daybue Stix: dissolve the whole packet in water or a water-based drink and give right away.
- Missed dose: take the next dose as scheduled and do not double up.
- Vomiting after a dose: do not repeat it. Take the next scheduled dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Rett syndrome
Patients 2 years and older weighing 9 kg to less than 12 kg Usual dose 5,000 mg twice a day
Good to know
Twice daily, morning and evening, with or without food
Patients 2 years and older weighing 12 kg to less than 20 kg Usual dose 6,000 mg twice a day
Good to know
Twice daily, morning and evening, with or without food
Patients 2 years and older weighing 20 kg to less than 35 kg Usual dose 8,000 mg twice a day
Good to know
Twice daily, morning and evening, with or without food
Patients 2 years and older weighing 35 kg to less than 50 kg Usual dose 10,000 mg twice a day
Good to know
Twice daily, morning and evening, with or without food
Patients 2 years and older weighing 50 kg or more Usual dose 12,000 mg twice a day
Good to know
Twice daily, morning and evening, with or without food
9 kg to under 12 kg Dose 2,500 mg twice daily
Good to know
Use Daybue oral solution to administer this dosage
Side Effects
The most common side effects are diarrhea and vomiting. Others reported more often than with placebo include:
Common side effects
- Diarrhea
- Vomiting
- Fever
- Seizure
- Anxiety
- Decreased appetite
- Fatigue
- Nasopharyngitis (stuffy or runny nose, common cold symptoms)
When to get medical help
- Tell your healthcare provider if diarrhea starts, especially if it is severe or you suspect dehydration.
- Call your provider if there is significant weight loss.
- Get help if vomiting is severe or keeps happening despite treatment.
- Seek urgent care for signs of aspiration (stomach contents or fluid getting into the lungs) or aspiration pneumonia after vomiting.
Contact your provider for severe diarrhea, signs of dehydration, notable weight loss, or severe or persistent vomiting.
Warnings and Precautions
- Diarrhea: very common and sometimes persistent. Stop laxatives before starting, drink more fluids, and tell your provider.
- Weight loss: weight should be monitored. Treatment may be paused, reduced, or stopped if it is significant.
- Vomiting: aspiration and aspiration pneumonia have occurred afterward, and people with Rett syndrome are at higher risk.
Interactions
Trofinetide can raise levels of certain other medicines.
- CYP3A and P-gp substrates: trofinetide inhibits these pathways, which may increase the effects of drugs that depend on them, so close monitoring is advised.
- Loperamide: blood levels rose in a study when taken with trofinetide.
- Laxatives: stop before starting, since diarrhea is common.
Interactions Listed in the FDA-Approved Label
From the Trofinetide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Sensitive CYP3A and/or P-gp substratesWhat happensTrofinetide, a weak inhibitor of CYP3A and an inhibitor of P-gp, increased the plasma concentrations of CYP3A and/or P-gp substrates, which may increase the risk of adverse reactions associated with these substrates.What to doClosely monitor patients when given with sensitive CYP3A and/or P-gp substrates where minimal increases in plasma concentration may lead to serious adverse reactions.
Read the label’s full interactions text
7 DRUG INTERACTIONS Orally administered CYP3A and/or P-gp sensitive substrates for which a small change in substrate plasma concentration may lead to serious adverse reactions: closely monitor for adverse reactions with concomitant use. 7.1 Effect of DAYBUE and DAYBUE STIX on Other Drugs CYP3A and/or P-gp Substrates Closely monitor patients when DAYBUE or DAYBUE STIX is administered concomitantly with sensitive CYP3A and/or P-gp substrates where minimal increases in the plasma concentration of these substrates may lead to serious adverse reactions. Trofinetide, a weak inhibitor of CYP3A and an inhibitor of P-gp, increased the plasma concentrations of CYP3A and/or P-gp substrates, which may increase the risk of adverse reactions associated with these substrates.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- There are no listed contraindications.
- Severe kidney impairment: not recommended.
- Moderate kidney impairment: a reduced dose is recommended.
- Pregnancy: not enough data in pregnant women.
- Breastfeeding: effects on milk or infant are unknown.
- Under 2 years old: safety and effectiveness not established.
- Age 65 and older: not studied, and kidney function may be monitored.
Half-Life and How Your Body Processes It
Trofinetide is well absorbed by mouth and peaks in the blood about 2 to 3 hours after a dose. A high-fat meal did not change total exposure. Its half-life is about 1.5 hours.
It is not significantly broken down by liver enzymes. About 80% leaves the body unchanged in urine. Moderate kidney impairment raises exposure by roughly 80%, which is why the dose is lowered.
Storage
Store DAYBUE in an upright position refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Store DAYBUE STIX packets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Trofinetide
From the licensed clinical database we use, rolled up per supplement, most serious first.30 supplements and herbal products have documented interactions with Trofinetide in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 1Major
- 19Moderate
- 10Minor
- ACTIVATED CHARCOALMajor
- ADRAFINILModerate
- CANNABIDIOL (CBD)Moderate
- CANNABINOL (CBN)Moderate
- CANNABISModerate
- COFFEE CHARCOALModerate
- DELTA-9-TETRAHYDROCANNABINOL (THC)Moderate
- ERGOTModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Trofinetide: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Trofinetide — the kind of thing our pharmacy team would talk through with you at the counter.
What is trofinetide for?
How do I give it?
What if a dose is missed or vomited?
Will diarrhea be a problem?
Are there other things I should watch for?
Does it interact with other medicines?
Is trofinetide available over the counter?
When was trofinetide first available?
What is the brand name of trofinetide?
What is the generic name of Daybue?
What strengths does trofinetide come in?
How much does trofinetide cost?
Is there a trofinetide shortage?
Where can I read the trofinetide prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Trofinetide
Skip the scrolling. Ask in your own words and get an answer from Trofinetide’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Trofinetide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Trofinetide on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Trofinetide Forms and Strengths (How It Comes)
Trofinetide comes in 1 dose form, the oral solution. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Trofinetide inactive ingredients by manufacturer.
Oral solution
How this form is used
- Daybue and Daybue Stix are both used to treat Rett syndrome in adults and children 2 years and older.
- Daybue is measured with a calibrated oral syringe or dosing cup from the pharmacy, not a household spoon. Discard unused solution 14 days after first opening the bottle.
- Daybue Stix powder is dissolved in cold or room-temperature water or a water-based drink, then given right away. Do not use partial packets or save a prepared dose.
- Daybue and Daybue Stix can be given by mouth or through a G tube, with or without food.
- For moderate kidney impairment needing a dose under a full packet, Daybue oral solution is recommended instead of Daybue Stix.
Trofinetide on the U.S. Market: Products, Makers and Brands
How Trofinetide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 4 Trofinetide product records with the FDA, mostly as oral solution; the earliest marketing or approval year on record is 2022. Brand names in the directory today include Daybue and Daybue Stix; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Trofinetide Is Used (Medicaid Data)
How many Trofinetide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Trofinetide prescribed? Of the 1,682 medications we measure, Trofinetide ranks #1,086 by Medicaid prescriptions — more than 35% of them.
Utilization by Trofinetide product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
trofinetide 200 MG/ML Oral Solution
1 of 1 listed NDCs had Medicaid claims. RxNorm 2632857
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 1 listed Trofinetide NDCs had Medicaid claims.
Compare Trofinetide Products
A representative set of FDA-listed product records for Trofinetide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Oral solution | ||||
| 200 mg/mL | Oral | Acadia Pharmaceuticals Inc. | NDA | View NDC → |
| 5000 mg | Oral | Acadia Pharmaceuticals Inc. | NDA | View NDC → |
| 6000 mg | Oral | Acadia Pharmaceuticals Inc. | NDA | View NDC → |
| 8000 mg | Oral | Acadia Pharmaceuticals Inc. | NDA | View NDC → |
Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Trofinetide NDCs →
Trofinetide Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Trofinetide — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Trofinetide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Trofinetide FDA Approval History
How Trofinetide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Trofinetide Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Trofinetide recalls since July 2021.
✅No Trofinetide recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Trofinetide in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 4
- Forms in current FDA listings
- 2 of 2
RxCUI 2632852 -
Dose form (SCDF) Oral SolutionIn current FDA listings
RxCUI 2632856Its strength (SCD)-
200 mg/mL
RxCUI 2632857
-
200 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Trofinetide Supply and Shortage Status
Whether Trofinetide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Medicaid Pays for Trofinetide
CMS’s weekly pharmacy survey (NADAC) has no price for Trofinetide, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.
| Form | Strength | Version | What Medicaid paid | |
|---|---|---|---|---|
| Oral solution · Oral | 200 mg/mL | Daybue (brand) | $23.73 per mL | NDC details & Medicaid use |
Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.
Trofinetide Brand Names
Trofinetide has 2 brand names on record: Daybue and Daybue Stix. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Trofinetide: Manufacturers and Labelers
One company lists Trofinetide products with the FDA. By number of product records, the largest are Acadia Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Trofinetide Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Acadia Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →